Preparation method of ginkgo extract for treating or preventing thrombus

The reflux extraction and column chromatography technology of the grinding and sieving of the white nuts was isolated, which solved the toxic side effects of ginkgo in clinical applications and realized the treatment of ginkgo extract or Effectiveness and safety in preventing thrombosis.

CN118948910APending Publication Date: 2024-11-15廖良坤
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411031100.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

In clinical applications, existing ginkgo fruits are difficult to achieve a small amount of toxic and side effects, but have good medicinal effects. In addition, polysaccharides, proteins, oils and other ingredients are ineffective or toxic during a single application, resulting in safety hazards.

Method used

The grinding and sieved green nuts are extracted for reflux, and the solution containing ethanol and ethyl acetate is extracted. Combined with column chromatography technology, the pH value and the composition of the eluent are adjusted to separate high content of flavonoids and lactones. , obtain ginkgo extract that has the effect of treating or preventing thrombosis.

Benefits of technology

The content of active substances in ginkgo extract was significantly improved, and the effect of taking a small amount of thrombosis was achieved. At the same time, the operation was simple, the reagents were used environmentally friendly and non-toxic, and it effectively removed ineffective or toxic ingredients. The wet weight of thrombosis in the experimental group was significantly reduced. , the inhibition rate can reach 73.31%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948910A_ABST
    Figure CN118948910A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of a ginkgo extract for treating or preventing thrombus, and relates to the technical field of medicines. The method comprises the following steps: preparing ginkgo seed powder, carrying out reflux extraction by using a solution containing ethanol and ethyl acetate to obtain an extracting solution, sequentially filtering, carrying out first concentration and centrifuging to obtain a mixed solution, adjusting the pH value to obtain a pretreated mixed solution, carrying out column chromatography, collecting an eluent, adjusting the pH value of the eluent, and carrying out second concentration and drying to obtain the ginkgo seed extract. According to the method, a solution containing ethanol and ethyl acetate is used as an extracting agent for reflux extraction, so that active substances including ginkgol, grease substances and the like in ginkgo seed powder can enter an extracting solution, the mixed solution is subjected to pH value regulation pretreatment, and the elution procedure and the composition of an eluent are controlled in a subsequent column chromatography process, so that the content of the active substances in the ginkgo seed powder is improved. The effective separation of active substances is promoted, and the ginkgo extract with high active substance content and good thrombus treatment or prevention effect is obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical technology, and in particular to a method for preparing a ginkgo extract capable of treating or preventing thrombosis. Background Art

[0002] Thrombi are small pieces of blood formed on the surface of the peeling or repairing of the inner surface of the cardiovascular system. In the variable fluid-dependent type, thrombi are composed of insoluble fibrin, deposited platelets, accumulated white blood cells and trapped red blood cells. At present, the raw materials of auxiliary health products for such diseases on the market are mainly some single-type Chinese medicine or raw materials of medicine and food homology.

[0003] Ginkgo is the dried mature seed of the Ginkgo biloba plant of the Ginkgoaceae family. The seeds are harvested when they mature in autumn, the fleshy outer seed coat is removed, washed, slightly steamed or slightly boiled, and then dried. In traditional clinical applications, ginkgo is used in combination, and there is no report of single application. And in actual applications, ginkgo is mostly used as a decoction. Therefore, the ineffective or even toxic components such as polysaccharides, proteins, oils, and ginkgolic acids contained in ginkgo are all taken, resulting in excessive clinical dosages and potential safety hazards. At present, the development and utilization of ginkgo has limitations, and the toxic and side effects of ginkgo are large. How to achieve taking a smaller amount of ginkgo to achieve better medicinal effects and less toxicity is the current development and research direction. Summary of the invention

[0004] The purpose of the present invention is to provide a method for preparing a ginkgo extract capable of treating or preventing thrombosis. Taking a small amount of the ginkgo extract obtained by the method provided by the present invention has a good effect of treating or preventing thrombosis.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a method for preparing a ginkgo extract capable of treating or preventing thrombosis, comprising the following steps:

[0007] (1) crushing and sieving the ginkgo kernels in sequence to obtain ginkgo kernel powder;

[0008] (2) refluxing the ginkgo kernel powder obtained in step (1) with a solution containing ethanol and ethyl acetate to obtain an extract;

[0009] The extract is filtered, first concentrated and centrifuged in sequence to obtain a mixed solution;

[0010] (3) adjusting the pH value of the mixed solution obtained in step (2) to 5 to 6.8 to obtain a pretreated mixed solution;

[0011] The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 50 vol.% to 75 vol.% ethanol solution, and finally eluted with a 95 vol.% ethanol solution, and the eluate of the 50 vol.% to 75 vol.% ethanol solution is collected;

[0012] The pH value of the eluate is adjusted to 6.5-6.9, and then the second concentration and drying are performed in sequence to obtain the ginkgo extract.

[0013] Preferably, the sieving in step (1) is through a 40-100 mesh sieve.

[0014] Preferably, the concentration of ethanol in the solution containing ethanol and ethyl acetate in step (2) is 50 vol.% to 75 vol.%, and the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is 10 vol.% to 20 vol.%.

[0015] Preferably, the number of reflux extractions in step (2) is 2 to 4 times; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is 1 kg: (1 to 6) L.

[0016] Preferably, the time for each reflux extraction in step (2) is 0.5 to 2 hours.

[0017] Preferably, in step (1), a nylon filter of 0.3 μm to 0.80 μm is used for filtering.

[0018] Preferably, the particle size of the macroporous resin used for column chromatography in step (3) is 0.20-1.30 mm, and the macroporous resin is DM-301, HP-20 or AB-8.

[0019] Preferably, in step (3), the pH value of the mixed solution is adjusted with hydrochloric acid, and the pH value of the eluent is adjusted with sodium hydroxide solution.

[0020] Preferably, the content of total flavonoids in the mixed solution in step (2) is 0.5wt.% to 1.5wt.%, the content of total polysaccharides in the mixed solution is 0.5wt.% to 6.5wt.%; and the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the mixed solution is ≥0.08wt.%.

[0021] Preferably, the content of total flavonoids in the ginkgo extract in step (3) is 20wt.% to 60wt.%, the content of total polysaccharides in the ginkgo extract is less than 2.0wt.%; and the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the ginkgo extract is ≥0.2wt.%.

[0022] The invention provides a preparation method of a ginkgo extract capable of treating or preventing thrombosis. The method comprises the following steps: firstly crushing and sieving ginkgo kernels in sequence to obtain ginkgo kernel powder, then refluxing and extracting the ginkgo kernels with a solution containing ethanol and ethyl acetate to obtain an extract, and then filtering, first concentrating and centrifuging the extract in sequence to obtain a mixed solution; adjusting the pH value of the mixed solution to 5-6.8 to obtain a pretreated mixed solution, and then using a macroporous resin wet column packing method to perform column chromatography, first washing the resin column with pure water, then eluting with a 50 vol.%-75 vol.% ethanol solution, and finally eluting with a 95 vol.% ethanol solution, collecting the eluate of the 50 vol.%-75 vol.% ethanol solution, adjusting the pH value of the eluate to 6.5-6.9, and then performing a second concentration and drying in sequence to obtain the ginkgo extract.

[0023] The invention uses a solution containing ethanol and ethyl acetate as an extractant for reflux extraction, which is beneficial for active substances including flavonoids, ginkgolide A, ginkgolide B, ginkgolide C, bilobalide and oil substances in ginkgo kernel powder to enter the extracting solution, performs a pretreatment of adjusting the pH value of the mixed solution, coordinates the control of the elution procedure and the composition of the eluent in the subsequent column chromatography process, promotes the effective separation of the active substances in the column chromatography process, and significantly improves the content of the active substances with the effect of treating or preventing thrombosis in the prepared ginkgo extract, thereby obtaining the ginkgo extract with good effect of treating or preventing thrombosis.

[0024] The method provided by the present invention is simple to operate, uses environmentally friendly and non-toxic reagents, and can effectively remove ineffective or toxic components in ginkgo. The results of the embodiment show that compared with the control group, the average wet weight of thrombus in the experimental group taking the ginkgo extract prepared in Examples 1 to 3 is significantly reduced, indicating that the ginkgo extract prepared in Examples 1 to 3 has a thrombus prevention effect; compared with the control group 2, the Amax of the experimental group taking the ginkgo extract prepared in Examples 1 to 3 is significantly reduced, and the inhibition rate can reach 73.31%, indicating that the ginkgo extract prepared in Examples 1 to 3 has an effect of inhibiting platelet aggregation. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 The HPLC chromatograms of the total lactone content in the reference solution of the present invention and the ginkgo extract sample solution prepared in Example 1, wherein: Figure 1 A is the reference solution. Figure 1 Wherein B is the sample solution of the ginkgo extract prepared in Example 1, BB represents bilobalide, GC represents ginkgolide C, GA represents ginkgolide A, and GB represents ginkgolide B. DETAILED DESCRIPTION

[0026] The present invention provides a method for preparing a ginkgo extract capable of treating or preventing thrombosis, comprising the following steps:

[0027] (1) crushing and sieving the ginkgo kernels in sequence to obtain ginkgo kernel powder;

[0028] (2) refluxing the ginkgo kernel powder obtained in step (1) with a solution containing ethanol and ethyl acetate to obtain an extract;

[0029] The extract is filtered, first concentrated and centrifuged in sequence to obtain a mixed solution;

[0030] (3) adjusting the pH value of the mixed solution obtained in step (2) to 5 to 6.8 to obtain a pretreated mixed solution;

[0031] The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 50 vol.% to 75 vol.% ethanol solution, and finally eluted with a 95 vol.% ethanol solution, and the eluate of the 50 vol.% to 75 vol.% ethanol solution is collected;

[0032] The pH value of the eluate is adjusted to 6.5-6.9, and then the second concentration and drying are performed in sequence to obtain the ginkgo extract.

[0033] In the present invention, unless otherwise specified, the raw materials used are conventional commercial products in the art.

[0034] The invention crushes and sieves the ginkgo kernels in sequence to obtain the ginkgo kernel powder.

[0035] The invention facilitates subsequent reflux extraction by pulverizing, thereby improving the extraction efficiency.

[0036] In the present invention, the sieving is preferably through a 40-100 mesh sieve, more preferably through a 50-80 mesh sieve.

[0037] After obtaining the ginkgo kernel powder, the invention uses a solution containing ethanol and ethyl acetate to reflux extract the ginkgo kernel powder to obtain an extract.

[0038] In the present invention, the concentration of ethanol in the solution containing ethanol and ethyl acetate is preferably 50 vol.% to 75 vol.%, more preferably 62 vol.% to 70 vol.%; the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is preferably 10 vol.% to 20 vol.%, more preferably 8 vol.% to 17 vol.%. The present invention controls the concentrations of ethanol and ethyl acetate in the solution extractant containing ethanol and ethyl acetate within the above range to adjust the polarity of the extract, which is beneficial for the active substances including ginkgo phenol and oil substances in the ginkgo kernel powder to enter the extract, thereby obtaining a ginkgo extract with good effect of treating or preventing thrombosis.

[0039] In the present invention, the number of reflux extractions is preferably 2 to 4 times, more preferably 3 times; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is preferably 1 kg: (1 to 6) L, more preferably 1 kg: (1.5 to 5) L. The present invention controls the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate within the above range to improve the extraction effect and extraction efficiency. In the present invention, the time of each reflux extraction is preferably 0.5 to 2 hours, more preferably 1 to 1.5 hours.

[0040] After obtaining the extract, the present invention sequentially filters, first concentrates and centrifuges the extract to obtain a mixed solution.

[0041] In the present invention, the filtration preferably uses a nylon filter of 0.3 μm to 0.80 μm. The present invention removes impurities by filtering. The present invention has no special restrictions on the first concentration method, and the solvent can be removed. The present invention has no special restrictions on the centrifugal method, and the particulate impurities can be further removed.

[0042] In the present invention, the content of total flavonoids in the mixed solution is preferably 0.5wt.% to 1.5wt.%, the content of total polysaccharides in the mixed solution is preferably 0.5wt.% to 6.5wt.%; the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the mixed solution is preferably ≥0.08wt.%.

[0043] After obtaining the mixed solution, the present invention adjusts the pH value of the mixed solution to 5-6.8 to obtain the pretreated mixed solution.

[0044] In the present invention, the pH value of the mixed solution is preferably adjusted with hydrochloric acid. The present invention promotes the effective separation of the active substance with the effect of treating or preventing thrombosis in the subsequent column chromatography process by adjusting the pH value of the mixed solution.

[0045] After obtaining the pretreated mixed solution, the present invention uses a macroporous resin wet column to perform column chromatography on the pretreated mixed solution, firstly washes the resin column with pure water, then elutes with a 50 vol.% to 75 vol.% ethanol solution, and finally elutes with a 95 vol.% ethanol solution, collects the eluate of the 50 vol.% to 75 vol.% ethanol solution; adjusts the pH value of the eluate to 6.5 to 6.9, and then sequentially performs a second concentration and drying to obtain the ginkgo extract.

[0046] The present invention uses the above elution procedure to elute the ineffective and toxic components in the pretreated mixed solution with pure water, and then uses 50vol.% to 75vol.% ethanol solution to elute the active substance with the effect of treating or preventing thrombosis, and effectively separates the active substance with the effect of treating or preventing thrombosis. In the present invention, the particle size of the macroporous resin used in the column chromatography is preferably 0.20 to 1.30 mm, more preferably 0.40 to 1.10 mm; the macroporous resin is preferably DM-301, HP-20 or AB-8.

[0047] In the present invention, the pH value of the eluent is preferably adjusted with sodium hydroxide solution.

[0048] In the present invention, the drying is preferably freeze drying, and the freeze drying temperature is preferably -60°C to -40°C, more preferably -55°C to -45°C. The present invention obtains a ginkgo extract with high activity and good medicinal effect through freeze drying.

[0049] In the present invention, the content of total flavonoids in the ginkgo extract is preferably 20wt.% to 60wt.%, and the content of total polysaccharides in the ginkgo extract is preferably <2.0wt.%; the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the ginkgo extract is preferably ≥0.2wt.%.

[0050] In the present invention, the ginkgo extract has the effects of preventing thrombosis and inhibiting platelet aggregation.

[0051] The technical solutions in the present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0052] Example 1

[0053] A method for preparing a ginkgo extract for treating or preventing thrombosis, comprising the following steps:

[0054] (1) using a pulverizer to grind the ginkgo kernels, and then passing through a 50-mesh sieve to obtain ginkgo kernel powder;

[0055] (2) refluxing and extracting the ginkgo kernel powder obtained in step (1) three times with a solution containing ethanol and ethyl acetate to obtain an extract;

[0056] The concentration of ethanol in the solution containing ethanol and ethyl acetate is 62 vol.%, and the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is 17 vol.%;

[0057] The time of each reflux extraction is 1 hour; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is 1kg:3L;

[0058] The extract is filtered through a 0.50 μm nylon filter, the obtained filtrate is subjected to reduced pressure distillation, i.e., first concentration, and then centrifuged to collect the supernatant to obtain a mixed solution;

[0059] (3) adjusting the pH value of the mixed solution obtained in step (2) to 6.5 with hydrochloric acid to obtain a pretreated mixed solution;

[0060] The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 65 vol. % ethanol solution, and finally eluted with a 95 vol. % ethanol solution, and the eluate of the 65 vol. % ethanol solution is collected;

[0061] The macroporous resin is DM-301 with a particle size of 0.50 mm;

[0062] The pH value of the eluate was adjusted to 6.8 with sodium hydroxide solution, and then vacuum distillation was performed, i.e., the second concentration was performed, and then freeze-dried at -55°C to obtain a ginkgo extract, which accounted for 6.3 wt% of the ginkgo kernel.

[0063] Example 2

[0064] A method for preparing a ginkgo extract for treating or preventing thrombosis, comprising the following steps:

[0065] (1) using a pulverizer to grind the ginkgo kernels, and then passing through a 50-mesh sieve to obtain ginkgo kernel powder;

[0066] (2) refluxing and extracting the ginkgo kernel powder obtained in step (1) three times with a solution containing ethanol and ethyl acetate to obtain an extract;

[0067] The concentration of ethanol in the solution containing ethanol and ethyl acetate is 64 vol.%, and the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is 15 vol.%;

[0068] The time of each reflux extraction is 1 hour; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is 1kg:3L;

[0069] The extract is filtered through a 0.50 μm nylon filter, the obtained filtrate is subjected to reduced pressure distillation, i.e., first concentration, and then centrifuged to collect the supernatant to obtain a mixed solution;

[0070] (3) adjusting the pH value of the mixed solution obtained in step (2) to 6.5 with hydrochloric acid to obtain a pretreated mixed solution;

[0071] The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 65 vol. % ethanol solution, and finally eluted with a 95 vol. % ethanol solution, and the eluate of the 65 vol. % ethanol solution is collected;

[0072] The macroporous resin is DM-301 with a particle size of 0.50 mm;

[0073] The pH value of the eluate was adjusted to 6.8 with sodium hydroxide solution, and then vacuum distillation was performed, i.e., the second concentration was performed, and then freeze-dried at -55°C to obtain a ginkgo extract, which accounted for 5.8wt% of the ginkgo kernel.

[0074] Example 3

[0075] A method for preparing a ginkgo extract for treating or preventing thrombosis, comprising the following steps:

[0076] (1) using a pulverizer to grind the ginkgo kernels, and then passing through a 50-mesh sieve to obtain ginkgo kernel powder;

[0077] (2) refluxing and extracting the ginkgo kernel powder obtained in step (1) three times with a solution containing ethanol and ethyl acetate to obtain an extract;

[0078] The concentration of ethanol in the solution containing ethanol and ethyl acetate is 68 vol.%, and the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is 13 vol.%;

[0079] The time of each reflux extraction is 1 hour; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is 1kg:3L;

[0080] The extract is filtered through a 0.50 μm nylon filter, the obtained filtrate is subjected to reduced pressure distillation, i.e., first concentration, and then centrifuged to collect the supernatant to obtain a mixed solution;

[0081] (3) adjusting the pH value of the mixed solution obtained in step (2) to 6.5 with hydrochloric acid to obtain a pretreated mixed solution;

[0082] The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 65 vol. % ethanol solution, and finally eluted with a 95 vol. % ethanol solution, and the eluate of the 65 vol. % ethanol solution is collected;

[0083] The macroporous resin is DM-301 with a particle size of 0.50 mm;

[0084] The pH value of the eluate was adjusted to 6.8 with sodium hydroxide solution, and then vacuum distillation was performed, i.e., the second concentration was performed, and then freeze-dried at -55°C to obtain the ginkgo extract, which accounted for 5.6wt% of the ginkgo kernel.

[0085] The ginkgo extracts prepared in Examples 1 to 3 were mixed with conventional auxiliary materials to prepare syrups, and the effective content of the ginkgo extracts in each bottle of syrup was 50%.

[0086] Test 1: Testing the content of active ingredients in the corresponding mixed solutions prepared in Examples 1 to 3 and the ginkgo extract

[0087] (1) Detection of total flavonoid content

[0088] Prepare a series of rutin standard solutions with different concentration gradients; then, accurately add 1.0 mL of 5% NaNO2 solution to each concentration of rutin standard solution, shake it thoroughly to make it evenly mixed, and let it stand for 5 minutes. Then add 1.0 mL of 10% Al(NO3)3 solution, mix it evenly, and let it stand for 5 minutes; after completing the above steps, add 10.0 mL of 4% NaOH solution to the solution, make up to volume with distilled water, shake it well and let it stand for 15 minutes; finally, measure the absorbance of these solutions at a wavelength of 510 nm, and analyze the relationship between the mass concentration (c) of rutin and the absorbance (A) by the linear regression method; through the above method, use the corresponding mixed solution prepared in Examples 1 to 3 and the ginkgo extract as samples, replace rutin, and detect the absorbance of the samples at a wavelength of 510 nm, and substitute the measured values ​​into the rutin standard curve equation to obtain the content of total flavonoids. The test results are shown in Tables 1 and 2.

[0089] (2) Detection of total polysaccharide content

[0090] 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8 mL of glucose standard solution were taken into a 10 mL stoppered test tube, and water was added to 1.0 mL in sequence; 1 mL of 5% phenol solution was added to each tube, and then 5 mL of sulfuric acid was quickly added, shaken to mix, and after standing at room temperature for 30 min, the absorbance was respectively measured at a wavelength of 490 nm by spectrophotometry; the concentration of glucose solution (mg / mL) was used as the abscissa and the absorbance (A) was used as the ordinate to draw a standard curve to obtain a regression equation; 1 mL of sample solution was taken into a stoppered test tube, 1 mL of 5% phenol solution was added, and then 5 mL of sulfuric acid was quickly added, shaken to mix, and after standing at room temperature for 30 min, the absorbance was measured at a wavelength of 490 nm by spectrophotometry; by the above method, the corresponding mixed solution prepared in Examples 1 to 3 and the ginkgo extract were respectively used as samples, the glucose solution was replaced, the absorbance of the samples was respectively detected, and the regression equation of the above glucose solution was substituted to respectively calculate the content of total polysaccharides in the samples. The test results are shown in Tables 1 and 2.

[0091] (3) The corresponding mixed solutions prepared in Examples 1 to 3 and the ginkgo extract were used as samples, respectively, and the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide (the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide combined, referred to as total lactones) in different samples was detected by the following method.

[0092] ① Preparation of standard solution

[0093] Weigh 10 mg of bilobalide, 10 mg of ginkgolide A, 10 mg of ginkgolide B, and 10 mg of ginkgolide C standard respectively, make up to volume with methanol in a 10 mL volumetric flask, mix well, and filter through a 0.22 μm filter membrane as the reference solution.

[0094] ②Sample processing

[0095] Take about 20g of sample, weigh it accurately, add petroleum ether to extract at 70℃ for 2h, discard the petroleum ether, add 200mL of methanol to extract for 4h, evaporate the extract to dryness, add methanol to dissolve the residue, transfer to a 10mL volumetric flask, ultrasonically treat for 30min, take out, cool, add methanol to the scale, shake well, let stand, accurately measure 5mL of supernatant, add to an acidic alumina column (200-300 mesh, 5g, inner diameter 1cm, wet packed with methanol), elute with 35mL of methanol, collect the eluate, recover the solvent to dryness, transfer the residue to a 5mL volumetric flask with methanol in batches, make up to the scale, shake well, and obtain the sample solution.

[0096] ③Chromatographic conditions

[0097] Chromatographic column: LP-C18, 5μm (4.6mm*250mm); mobile phase: methanol-0.2% formic acid aqueous solution (24:76); flow rate: 1.0mL / min; column temperature: 35°C; UV detection wavelength: 220nm; injection volume: 10μL.

[0098] ④Calculation

[0099] The contents of Ginkgolide A, Ginkgolide B, Ginkgolide C and Bilobalide were quantitatively calculated by external standard method according to the corresponding peak areas in the samples. The total lactone content is the sum of the contents of the above four lactones. The results are shown in Tables 1, 2 and Figure 1 .

[0100] Table 1 Content of active ingredients in the mixed solution prepared in Examples 1 to 3

[0101] sample Total flavonoids content (%) Total polysaccharide content (%) Total lactone content (%) Mixed solution prepared in Example 1 0.61 0.59 0.08 Mixed solution prepared in Example 2 0.92 6.3 0.12 Mixed solution prepared in Example 3 1.46 5.9 0.13

[0102] Table 2 Content of active ingredients in ginkgo extracts prepared in Examples 1 to 3

[0103] sample Total flavonoids content (%) Total polysaccharide content (%) Total lactone content (%) Example 1 Ginkgo extract prepared 35.3 1.29 0.23 Example 2 Preparation of Ginkgo Extract 49.2 0.56 0.29 Example 3 Ginkgo extract prepared 53.7 0.82 0.41

[0104] Figure 1 The HPLC chromatograms of the total lactone content in the reference solution of the present invention and the ginkgo extract sample solution prepared in Example 1, wherein: Figure 1 A is the reference solution. Figure 1 Wherein B is the sample solution of the ginkgo extract prepared in Example 1, BB represents bilobalide, GC represents ginkgolide C, GA represents ginkgolide A, and GB represents ginkgolide B. Figure 1 It can be seen that the ginkgo extract obtained by the present invention is rich in bilobalide and other substances with anti-thrombotic effects.

[0105] Test 2: In vitro rat thrombolysis experiment

[0106] The effect on thrombosis in rats was determined by thrombus method. The specific steps are as follows:

[0107] 40 SD rats weighing 300-400 g were randomly divided into blank control, experimental group 1, experimental group 2 and experimental group 3, with 10 rats in each group; the experimental group 1, experimental group 2 and experimental group 3 were intragastrically administered with 30 mg / kg of the syrup prepared from the ginkgo extract prepared in Examples 1-3, and the blank control group was intragastrically administered with an equal amount of physiological saline once a day for 5 days; on the 5th day of administration, the rats were weighed 1 hour after the last administration, and then i.v. Anesthesia was performed with 1 ml / kg of 3% sodium pentobarbital, and the animals were fixed in the supine position. A midline incision was made in the neck, and the trachea and bilateral common carotid arteries were separated. A 6 cm 50 silk thread was passed through the polyethylene tube, and the polyethylene tube was filled with heparin saline solution. After one end of the polyethylene tube was inserted into the left external jugular vein, heparin anticoagulation was accurately injected through the polyethylene tube. The other end of the polyethylene tube was then inserted into the right carotid artery, and the arterial clamp was opened to create an AV bypass. The blood flow was opened for 15 minutes, the silicone tube was removed, and the silk thread (containing the thrombus) was drawn out and placed in a weighed small culture dish according to the number. The wet weight of the thrombus was weighed on an analytical balance, and the weight of the thrombus was obtained by subtracting the weight of the silk thread from the total weight. The experimental results are shown in Table 1.

[0108] Table 1 Comparison of thrombus weight among experimental group 1, experimental group 2, experimental group 3 and control group

[0109] Group drug Average thrombus wet weight (mg) Control group Normal saline 46.11 Experimental group Example 1 Ginkgo extract prepared 10.15 Experimental Group 2 Example 1 Ginkgo extract prepared 9.61 Experimental Group 3 Example 1 Ginkgo extract prepared 9.23

[0110] As shown in Table 1, compared with the control group, the average wet weight of thrombus in the experimental group taking the ginkgo extract prepared in Examples 1 to 3 was significantly reduced, indicating that the ginkgo extract prepared in Examples 1 to 3 has the effect of preventing thrombosis.

[0111] Test 3: Effect on platelet aggregation in rats (turbidimetric method)

[0112] Take 40 SD rats weighing 300-400 grams, half male and half female, and randomly divide them into blank control, experimental group 4, experimental group 5, and experimental group 6, with 10 rats in each group; Experimental group 4, experimental group 5, and experimental group 6 were gavaged with syrup prepared from the ginkgo extract prepared in Examples 1-3 at a dosage of 30 mg / kg, and blank control group 2 was gavaged with an equal amount of physiological water, once a day for a total of 7 days; on the 7th day of administration of rats, blood was collected from the posterior ophthalmic artery of the rats half an hour after the last administration, and 0.13% sodium thiazide was used for anticoagulation (the volume ratio of blood to anticoagulant was 9:1), and the blood was injected into a siliconized test tube, and the mouth of the centrifuge tube was covered with a plastic film, and the centrifuge tube was inverted 3-4 times to fully mix the blood and the anticoagulant, and the residual blood attached to the tube wall was absorbed with clean filter paper, and the centrifuge tube was tightly covered; centrifuged at 1000r / min for 10 minutes, the upper plasma (PRP) was carefully removed, and the remaining plasma was centrifuged at 300r / min. 0r / min centrifugation for 20 minutes, the lower transparent liquid is PPP, count the number of platelets in PRP, and use PPP to adjust the platelets in PRP to 200×109 / L; use a siliconized pipette to take PPP and PRP450u1 and place them in turbidity tubes respectively. When measuring, first adjust the transmittance of the recorder to 100 with the PPP sample, then put the PRP sample into the measurement hole, adjust the transmittance to 10, and add a stirring magnetic bar, preheat at 37℃ for 3 minutes, turn on the recorder, add ADP to induce platelet aggregation agent to PRP, CHROND-Log platelet aggregation instrument (USA), calculate the maximum platelet aggregation rate (%) through the aggregation curve, (Amax) = h1 / h0×100%; platelet aggregation inhibition rate, inhibition rate = [(normal saline Amax-drug Amax) / normal saline Amax]×100%, the experimental results are shown in Table 2

[0113] Table 2 Comparison of thrombus weight among experimental group 4, experimental group 5, experimental group 6 and control group 2

[0114]

[0115]

[0116] As shown in Table 2, compared with the control group 2, the Amax of the experimental group taking the ginkgo extract prepared in Examples 1 to 3 was significantly reduced, and the inhibition rate could reach 73.31%, indicating that the ginkgo extract prepared in Examples 1 to 3 has the effect of inhibiting platelet aggregation.

[0117] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing a ginkgo extract for treating or preventing thrombosis, characterized in that: The following steps are involved: (1) crushing and sieving the ginkgo kernels in sequence to obtain ginkgo kernel powder; (2) refluxing the ginkgo kernel powder obtained in step (1) with a solution containing ethanol and ethyl acetate to obtain an extract; The extract is filtered, first concentrated and centrifuged in sequence to obtain a mixed solution; (3) adjusting the pH value of the mixed solution obtained in step (2) to 5 to 6.8 to obtain a pretreated mixed solution; The pretreated mixed solution is loaded with a macroporous resin wet column for column chromatography, the resin column is first washed with pure water, then eluted with a 50 vol.% to 75 vol.% ethanol solution, and finally eluted with a 95 vol.% ethanol solution, and the eluate of the 50 vol.% to 75 vol.% ethanol solution is collected; The pH value of the eluate is adjusted to 6.5-6.9, and then the second concentration and drying are performed in sequence to obtain the ginkgo extract.

2. The preparation method according to claim 1, characterized in that: The sieving in step (1) is performed through a 40-100 mesh sieve.

3. The preparation method according to claim 1, characterized in that: The concentration of ethanol in the solution containing ethanol and ethyl acetate in step (2) is 50 vol.% to 75 vol.%, and the concentration of ethyl acetate in the solution containing ethanol and ethyl acetate is 10 vol.% to 20 vol.%.

4. The preparation method according to claim 1, characterized in that: The number of reflux extractions in step (2) is 2 to 4 times; during each reflux extraction, the ratio of the mass of the ginkgo kernel powder to the volume of the solution containing ethanol and ethyl acetate is 1 kg: (1 to 6) L.

5. The preparation method according to claim 1 or 5, characterized in that: The time of each reflux extraction in step (2) is 0.5 to 2 hours.

6. The preparation method according to claim 1, characterized in that: In the step (1), a nylon filter with a diameter of 0.3 μm to 0.80 μm is used for filtering.

7. The preparation method according to claim 1, characterized in that: The particle size of the macroporous resin used for column chromatography in step (3) is 0.20-1.30 mm, and the macroporous resin is DM-301, HP-20 or AB-8.

8. The preparation method according to claim 1, characterized in that: In the step (3), the pH value of the mixed solution is adjusted with hydrochloric acid, and the pH value of the eluent is adjusted with sodium hydroxide solution.

9. The preparation method according to claim 1, characterized in that: In the step (2), the content of total flavonoids in the mixed solution is 0.5wt.% to 1.5wt.%, the content of total polysaccharides in the mixed solution is 0.5wt.% to 6.5wt.%; the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the mixed solution is ≥0.08wt.%.

10. The preparation method according to claim 1, characterized in that: In the step (3), the content of total flavonoids in the ginkgo extract is 20wt.% to 60wt.%, the content of total polysaccharides in the ginkgo extract is less than 2.0wt.%; and the total content of ginkgolide A, ginkgolide B, ginkgolide C and bilobalide in the ginkgo extract is ≥0.2%.

Citation Information

Patent Citations

  • Gingkgo active ingredient extraction and separation method and use of extracted active matters in medicines for treating cardiovascular and cerebrovascular diseases

    CN102416027A

  • Ginkgo leaf refinement extract adopting ginkgo fallen leaves as raw material, preparation method and application thereof

    CN103463145A

  • Deep processing method of ginkgo nut endosperm

    CN109793233A